These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2191770)
1. Mutational analysis of the H-ras oncogene in spontaneous C57BL/6 x C3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens. Fox TR; Schumann AM; Watanabe PG; Yano BL; Maher VM; McCormick JJ Cancer Res; 1990 Jul; 50(13):4014-9. PubMed ID: 2191770 [TBL] [Abstract][Full Text] [Related]
2. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene. Goodrow T; Reynolds S; Maronpot R; Anderson M Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119 [TBL] [Abstract][Full Text] [Related]
3. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice. Wang Y; Wang Y; Stoner G; You M Cancer Res; 1993 Apr; 53(7):1620-4. PubMed ID: 8453632 [TBL] [Abstract][Full Text] [Related]
4. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis. Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584 [TBL] [Abstract][Full Text] [Related]
5. ras gene activation in rat tumors induced by benzidine congeners and derived dyes. Reynolds SH; Patterson RM; Mennear JH; Maronpot RR; Anderson MW Cancer Res; 1990 Jan; 50(2):266-72. PubMed ID: 2403837 [TBL] [Abstract][Full Text] [Related]
6. Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice. Manam S; Storer RD; Prahalada S; Leander KR; Kraynak AR; Ledwith BJ; van Zwieten MJ; Bradley MO; Nichols WW Cancer Res; 1992 Jun; 52(12):3347-52. PubMed ID: 1596892 [TBL] [Abstract][Full Text] [Related]
7. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice. Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158 [TBL] [Abstract][Full Text] [Related]
9. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors. Vorce RL; Goodman JI Mol Toxicol; 1989; 2(2):99-116. PubMed ID: 2702305 [TBL] [Abstract][Full Text] [Related]
10. Analysis of activated protooncogenes in B6C3F1 mouse liver tumors induced by ciprofibrate, a potent peroxisome proliferator. Hegi ME; Fox TR; Belinsky SA; Devereux TR; Anderson MW Carcinogenesis; 1993 Jan; 14(1):145-9. PubMed ID: 8425263 [TBL] [Abstract][Full Text] [Related]
11. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors. Vorce RL; Goodman JI J Toxicol Environ Health; 1991 Nov; 34(3):367-84. PubMed ID: 1658350 [TBL] [Abstract][Full Text] [Related]
12. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2. Przygodzki RM; Finkelstein SD; Keohavong P; Zhu D; Bakker A; Swalsky PA; Soini Y; Ishak KG; Bennett WP Lab Invest; 1997 Jan; 76(1):153-9. PubMed ID: 9010458 [TBL] [Abstract][Full Text] [Related]
13. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine. Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014 [TBL] [Abstract][Full Text] [Related]
14. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632 [TBL] [Abstract][Full Text] [Related]
15. Oncogene involvement in tumor regression: H-ras activation in the rabbit keratoacanthoma model. Corominas M; Leon J; Kamino H; Cruz-Alvarez M; Novick SC; Pellicer A Oncogene; 1991 Apr; 6(4):645-51. PubMed ID: 1840681 [TBL] [Abstract][Full Text] [Related]
16. Spontaneous and thiazolidinedione-induced B6C3F1 mouse hemangiosarcomas exhibit low ras oncogene mutation frequencies. Duddy SK; Gorospe SM; Bleavins MR; de la Iglesia FA Toxicol Appl Pharmacol; 1999 Oct; 160(2):133-40. PubMed ID: 10527912 [TBL] [Abstract][Full Text] [Related]
17. Infrequent activation of K-ras, H-ras, and other oncogenes in hepatocellular neoplasms initiated by methyl(acetoxymethyl)nitrosamine, a methylating agent, and promoted by phenobarbital in F344 rats. Watatani M; Perantoni AO; Reed CD; Enomoto T; Wenk ML; Rice JM Cancer Res; 1989 Mar; 49(5):1103-9. PubMed ID: 2645046 [TBL] [Abstract][Full Text] [Related]
18. Incidence of mutations at codon 61 of the Ha-ras gene in liver tumors of mice genetically susceptible and resistant to hepatocarcinogenesis. Dragani TA; Manenti G; Colombo BM; Falvella FS; Gariboldi M; Pierotti MA; Della Porta G Oncogene; 1991 Feb; 6(2):333-8. PubMed ID: 2000226 [TBL] [Abstract][Full Text] [Related]
19. DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo[a]pyrene. Culp SJ; Warbritton AR; Smith BA; Li EE; Beland FA Carcinogenesis; 2000 Jul; 21(7):1433-40. PubMed ID: 10874023 [TBL] [Abstract][Full Text] [Related]
20. Activation of H-ras oncogenes in preneoplastic mouse mammary tissues. Kumar R; Medina D; Sukumar S Oncogene; 1990 Aug; 5(8):1271-7. PubMed ID: 2118247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]